OpenAlex
PricingAboutJobs
Log inGet started
Work

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

HTML

Year: 2016
Type: review
Source: Nature Reviews Clinical Oncology
DOI: 10.1038/nrclinonc.2016.139
Authors: Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, Michele Baccarani
Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: tyrosine kinase inhibitors, chronic myeloid leukemia, frontline treatment, second-line therapy, treatment resistance, treatment intolerance, treatment selection, overall survival, treatment-free remission, response monitoring, prognostic factors
SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Ariad Pharmaceuticals
OpenAlex ID: W2532456746
FWCI: 2.922
Cites: 130
Cited by: 184
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security